Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Non-Current Deferred Tax Liability (2019 - 2021)

SELLAS Life Sciences (SLS) has disclosed Non-Current Deferred Tax Liability for 3 consecutive years, with $239000.0 as the latest value for Q3 2021.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 8.78% to $239000.0 in Q3 2021 year-over-year; TTM through Sep 2021 was $239000.0, a 8.78% decrease, with the full-year FY2020 number at $1.4 million, up 428.63% from a year prior.
  • Non-Current Deferred Tax Liability was $239000.0 for Q3 2021 at SELLAS Life Sciences, roughly flat from $239000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.4 million in Q4 2020 to a low of $239000.0 in Q1 2021.
  • A 3-year average of $383727.3 and a median of $262000.0 in 2019 define the central range for Non-Current Deferred Tax Liability.
  • Biggest YoY gain for Non-Current Deferred Tax Liability was 428.63% in 2020; the steepest drop was 26.61% in 2020.
  • SELLAS Life Sciences' Non-Current Deferred Tax Liability stood at $262000.0 in 2019, then soared by 428.63% to $1.4 million in 2020, then crashed by 82.74% to $239000.0 in 2021.
  • Per Business Quant, the three most recent readings for SLS's Non-Current Deferred Tax Liability are $239000.0 (Q3 2021), $239000.0 (Q2 2021), and $239000.0 (Q1 2021).